ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 75 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 6.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $16,000 | -73.3% | 11,049 | -37.3% | 0.00% | – |
| Q3 2017 | $60,000 | -3.2% | 17,613 | +19.9% | 0.00% | – |
| Q3 2016 | $62,000 | +21.6% | 14,692 | -31.4% | 0.00% | – |
| Q2 2016 | $51,000 | -51.9% | 21,426 | -6.5% | 0.00% | – |
| Q2 2015 | $106,000 | -66.5% | 22,906 | -51.1% | 0.00% | – |
| Q1 2015 | $316,000 | +247.3% | 46,886 | +66.3% | 0.00% | – |
| Q4 2014 | $91,000 | – | 28,186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 1,641,025 | $7,549,000 | 1.29% |
| Squarepoint Ops LLC | 10,200 | $47,000 | 0.02% |
| DELTEC ASSET MANAGEMENT LLC | 15,000 | $69,000 | 0.02% |
| FIRST NEW YORK SECURITIES LLC /NY | 5,700 | $26,220,000 | 0.01% |
| WEDBUSH SECURITIES INC | 11,033 | $51,000 | 0.01% |
| Allen Investment Management, LLC | 15,524 | $71,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 14,512 | $67,000 | 0.01% |
| A.R.T. Advisors, LLC | 19,216 | $88,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 134,102 | $617,000 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 17,105 | $79,000 | 0.00% |